The Council is composed of Regional Board Chairs and Deputy Chairs from each of the ten ISN regions. It works alongside the Executive Committee to determine effective policies, strategy, and governance to carry out ISN’s mission.
Meet the members of the Council (2021-2023):
Fatiu Abiola Arogundade
Fatiu Abiola Arogundade
I was born in Rijeka, Croatia in 1964. I graduated at the Faculty of Medicine in Rijeka in 1990. I completed my postgraduate studies in Rijeka, and part of my specialist training in Vienna. My area of scientific interest is nephrology, especially dialysis and kidney transplantation. In the last 20 years, I have published a total of 350 scientific and professional papers. I actively participated in all congresses of the Croatian Society for Nephrology, Dialysis and Transplantation, of which I was president for 4 years. I was an invited lecturer and chair of plenary sessions of a large number of nephrology meetings and conferences. I have given about 50 invited lectures at international conferences and about 200 invited lectures at domestic conferences. I am a founder and current president of the distinguished national symposium “DiaTransplant”, which is held every 3 years.
I have led 18 international clinical trials as principal investigator at the home institution. Since 2005 I have been a reviewer in 10 scientific journals and a member of the editorial board in 3 journals. Since 2016, I have been a full member of the Croatian Academy of Medical Sciences. I have received several awards and recognitions for my scientific work. I was a mentor of 10 qualifying papers, editor of 2 university textbooks and author of 11 chapters in books. Since 2001, I have been the head of the Department of Nephrology, Dialysis and Kidney Transplantation at the Clinical Hospital Center Rijeka and a full professor at the Department of Internal Medicine, Faculty of Medicine, University of Rijeka. Currently, I am a Board member of the Croatian Medical Association in Rijeka, Croatian Society for Nephrology, Dialysis and Transplantation and Croatian Obesity Society and member of the several Boards of the International Associations – International Society of Nephrology (Eastern and Central Europe Regional Board), Balkan Association of Nephrology, Dialysis and Artificial Organs (BANTAO) and Mediterranean Kidney Society.
Dr. Rulan Parekh is a clinician scientist, nephrologist and an international leader in clinical epidemiology and translational research in kidney disease. Her body of work has revealed novel genetic risk factors leading to kidney disease, and increased risk of cardiovascular morbidity and mortality for children and adults with kidney disease. At the University of Michigan, Dr. Parekh was uniquely trained in Pediatrics and Internal Medicine with subspecialty training in both Pediatric and Adult Nephrology as well as research training, completing her Master’s in Biostatistics and Study Design. She subsequently went on to post-doctoral training at Johns Hopkins University and joined the faculty in 2000. She successfully competed for a NIH Career Development Research Award, and the American Society of Nephrology Carl W. Gottschalk Award for young investigators, establishing successful research programs in the genetics and cardiovascular complications of kidney disease. In 2008, she returned back to her native Canada and accepted a faculty position at the University of Toronto (UofT) and a Scientist position within the SickKids Research Institute. Since 2000, Dr. Parekh has maintained a record of sustained NIH and CIHR funding. She has significant productivity with more than 160 published manuscripts over 4000 citations and a stellar track record of training and mentoring 80 students and post-doctoral trainees. She has received several awards including the National Kidney Foundation of Maryland Award, Advising, Mentoring and Teaching Research Award and was elected into academic honor societies such as the American Society of Clinical Investigation, the Pediatric Academic Society and the American Pediatric Society. Dr. Parekh has recently been named Canada Research Chair in Chronic Kidney Disease Epidemiology by the Canadian Institutes of Health Research.
Dr Gloria Ashuntantang is a consultant nephrologist at the Yaounde General Hospital and Professor of medicine at the University of Yaounde I in Cameroon where she also serves as Vice-Dean of the faculty of Medicine & Biomedical Sciences. She is holder of the MB; BS (University of Ibadan in Nigeria), Certificate of specialisation in internal medicine (University of Yaounde I), and Diplôme de Médecin Spécialiste en néphrologie and an MD (University of Geneva, Switzerland). Her main area of research is ESKD and Acute Kidney Injury in sub-Saharan Africa. She has co-authored over 40 peer-review papers and a book chapter. She is a member of the African association of Nephrology (AFRAN), ERA-EDTA, and the ISN. She has contributed to the growth of nephrology in her home country through mentorship, hosting of ISN educational ambassadors and ISN CME courses. She has also mentored several young nephrologists some of whom have been beneficiaries of the ISN and ERA-EDTA fellowships. She is a member of the ISN CME and fellowship committees, deputy Chair of the ISN Africa regional board, President of AFRAN and founding president of the Cameroon Society of nephrology. She is a member of the ISN Executive committee (2017-2019). She is a distinguished fellow of the European Renal Association and Knight of the Cameroon Order of Valour. She is married and a mother. She writes and speaks English and French fluently.
Ali K. Abu-Alfa
Ali K. Abu-Alfa
MD, FASN, FAHA
Dr Ali Abu-Alfa is a Professor of Medicine, and Head of the Division of Nephrology and Hypertension at the American University of Beirut (AUB). He is the Director for the Human Research Protection Program at AUB, and for Research Affairs at AUB Medical Center. He joined AUB in 2010 after spending 2 decades at the Yale School of Medicine in New Haven, CT, USA where he directed the Peritoneal Dialysis (PD) program and the clinical trials program in nephrology.
He earned his MD degree from AUB in 1985, completed a residency in Internal Medicine at Northwestern in 1990 and a fellowship in Nephrology at Yale in 1993. He is board-certified by the American Board of Internal Medicine-Nephrology, is a Specialist in Clinical Hypertension and a Fellow of the American Heart Association and a member of its hypertension council.
He is a member of the ISN Middle East Regional Board, as well as the ISN Dialysis Committee. He is currently the President for the Lebanese Society of Nephrology and Hypertension.
In December 2014, he launched and is serving as founding President of the Middle East Chapter of the International Society for Peritoneal Dialysis. He has previously served as co-President of the North American Chapter of ISPD from 2008 to 2011. He recently completed a 3 years term as member of the KDIGO Executive committee.
In addition to his strong engagement in these regional and international nephrology circles, Dr Abu-Alfa’s continues to pursue his scientific interests in the areas of PD, complex hypertension, CKD-MBD, imaging issues in renal patients including Nephrogenic Systemic Fibrosis and use of Gadolinium Based Contrast Agents. He is also very active in the sphere of research ethics, its regulatory framework, the protection of human subjects in research and the establishment of regional and international research collaborations.
From 1989 to 2015: Director of Nephrology, Dialysis and Transplantation, Regina Margherita Children’s University Hospital, Turin and Professor of Pediatric Nephrology at the University of Turin, Italy .
Field of research: glomerular diseases in children and adults, with particular focus on IgA nephropathy and IgA vasculitis, from the pathogenetical mechanisms to risk factors for progression and therapy. Founder and Coordinator of the Immunonephrology Working Group (IWG) ERA-EDTA (2009-2015).
ISN Councillor, Deputy Chair of the ISN Western Europe
Secretary General European Society Paediatric Nephrology (ESPN) (2012- 2015)
Chairperson ERA-EDTA Administrative Office (2005- 2012)
Chairperson ERA-EDTA CME programme (2003-2009)
She received the 2016 ERA-EDTA Award for Outstanding Contributions to Nephrology.
Her activities in the ISN have been devoted to the Sister Renal Center program, the Awards Committee and in support to the Chair of the ISN Western Europe in developing projects for ISN members in this area
After my graduation, I did a specialization and PhD in Nephrology. Then, I’ve worked as a research doctor in Immunology and Nephrology at the Medical School of University of São Paulo (FMUSP) for almost 14 years. During my stay, I mentored many medical school undergraduate students. At this time, I’ve developed works in areas such experimental transplantation, chronic kidney disease as secondary immunodeficiency cause and immunomodulatory effects of PTH and vitamin D.
My experience in several fields of nephrological knowledge and an MBA in Health Management allowed me to open clinics to assist patients with CKD, providing hemodialysis, hemodiafiltration, daily dialysis, incremental dialysis and peritoneal dialysis services. At my clinics, I also provided care for patients with acute renal failure. Simultaneously, I worked in my office with emphasis on prevention of CKD and care of renal patients. In the meantime, I founded the Google Group Nefroforum, which brings together more than 800 Brazilian nephrologists to exchange experiences and knowledge. I’ve returned to FMUSP when I was offered the coordination of the Public Dialysis Unit II/Osasco. In this position, I stayed for two years, and expanded my management activities of dialysis clinics, giving advice and classes on the subject.
Few years ago, I accepted the challenge of being the President of the Brazilian Society of Nephrology (BSN), where my main goals were educational and social activities and health policy. The good results obtained led to my re-election. After that, I was chosen vice-president of SLANH and I was accepted as a member of Clinical Research Committee of the ISN.
Recently, I was elected Director of the BSN Department of Education and Certification and I have expanded my interests in home dialysis to fields such as administration and palliative care. Currently, I am also dedicated to the study of aging and neurological changes in patients on dialysis, in partnership with the Laboratory of Neuropharmacology (ICB-USP).
Dr. Larisa Prikhodina is Professor of Pediatrics and Head Researcher of the Department of Inherited & Acquired Kidney Diseases, Research & Clinical Institute for Pediatrics n. a. acad. Y.E. Veltishev, Pirogov Russian National Research Medical University and Department of Pediatrics, Russian Medical Academy of Postgraduate Education, Moscow, Russia. She received her M.D. in 1994 at Pirogov Russian National Research Medical University. She performed scholarships in pediatric nephrology at the Institute of Child Health and Great Ormond Street Hospital, London, the UK, the Hannover Kinderklinic, Germany and Hospital Katholieke University, Leuven, Belgium.
Her research interests include the genetic basis of steroid-resistant nephrotic syndrome and hereditary kidney diseases, the risk factors of CNI-mediated nephrotoxicity in pediatric nephrotic syndrome, physiopathology and prevention of kidney disease progression.
She is actively involved to numerous international research clinical trials including the PodoNet (Clinical, Genetic and Experimental Research into Hereditary Diseases of the Podocytes), Autosomal Recessive Polycystic Kidney Disease Registry (ARegPKD), Autosomal Dominant Polycystic Kidney Disease Registry (ADPedKD), OxalEurope (Genotype/phenotype correlations in patients with primary hyperoxaluria), Genome-Wide Analysis in Steroid-Sensitive Nephrotic Syndrome, Genotype-phenotype associations in Dent disease, Non-invasive biomarkers of HNF1β nephropathy, the European Society for Paediatric Nephrology (ESPN) study of pediatric renal care in Europe
Dr. Prikhodina has served on multiple professional boards including the ISN Sister Renal Centers Program Committee, the Councils of the International Pediatric Nephrology Association (IPNA), ESPN, the Scientific Society of Nephrologists of Russia and the Russian Association of Pediatric Nephrology. She was a member of Scientific committees of the 16th-18th IPNA Meetings, 45th, 48th and 51st ESPN Meetings.
She won several international awards, including The Best Abstract (50th ESPN Meeting, 2017) and Poster Presentation Award (World Congress of Nephrology, 2003), National Grant of ERAEDTA (2006). Dr. Prikhodina’s publication record encompasses 225 scientific articles in Russian and International Journals and book chapters. With more than 199 citations to date, her current HIndex is 8. Dr. Prikhodina also has reviewed papers at several international journals, including Pediatric Nephrology, Journal of Nephrology, BMC Pediatrics.
Magdalena Madero, MD, is the Chief of Nephrology at the National Heart Institute in Mexico City. As part of her educational activities she runs one of the largest renal fellowship programs in the country. She is involved in CKD progression , CKDu and Hemodialysis research. She was the former President of one of the Mexican Societies of Nephrology (IMIN) and serves as International Editor for the American Journal of Kidney Diseases (2016-2021) and as a member of the Kidney Disease Improving Global Outcomes Executive Committee (2018-2021). She was chosen as Deputy Chair for the International Society of Nephrology (ISN) for Latin America and the Caribbean (2019-2023).
My research focus lies at the intersection of global health and nephrology. I believe deeply in Paul Farmer’s statement that “The idea that some lives matter less is the root of all that is wrong with the world.” As a first generation immigrant, I strive to apply the same rigor and depth I apply to the patients I see in my clinic at Stanford, to my clinical work and research initiatives abroad.
After completing my medical school at Washington University in St. Louis, internal medicine residency at Brigham and Women’s Hospital, and nephrology fellowship and Masters in Clinical Epidemiology at Stanford University, I received a K-23 to study chronic kidney disease in South Asians. In partnership with the Public Health Foundation of India, I studied prevalence, risks factors, and outcomes of CKD in urban India, and identified strategies for screening. I served as an Editor for the World Bank’s Disease Control Priorities initiative on rational and cost-effective health care policies for resource-constrained settings. I am investigating the chronic kidney disease of uncertain etiology epidemic occurring in agricultural communities worldwide, a research focus for which I have worked with the ISN to launch collaborative initiatives. I am the Nephrology Rotation Director for Stanford; three nephrology fellows I work with have successfully received grants to pursue projects in global health and international settings.
Angela Yee-Moon Wang
Angela Yee-Moon Wang
Dr Angela Yee-Moon WANG, MD, PhD, FHKAM, FHKCP, FRCP (Lond & Edin), was graduated from the University of New South Wales, Australia and is a staff nephrologist and clinician scientist at the Queen Mary Hospital, University of Hong Kong, Hong Kong.
She is the current President of International Society of Renal Nutrition and Metabolism (ISRNM), Regional Board member of ISN, Council member of International Society of Peritoneal Dialysis (ISPD), Core group member of Asia Chapter ISPD, Executive Committee member of SONG Initiative and previous Executive Committee Member of KDIGO. She is a committee member of ISN-Advancing Clinical Trial and Subject Editor of ISN Academy.
Angela has chaired the ISPD Adult Cardiovascular and Metabolic Guidelines 2015 and was a workgroup member of Kidney Disease Outcome Quality Initiative (KDOQI) nutrition guidelinesin CKD 2020, ISPD Prescribing high quality PD practice recommendations 2020, ISPD-Global Renal Exercise group (GREX) exercise recommendations in PD 2020 and KDIGO – CKD-Mineral Bone Disease guidelines 2009.
Angela has received several international research-related awards including Joel D. Kopple Award 2018 of United States National Kidney Foundation, Travelling Lecturer Award of Asia Pacific Federation of Clinical Biochemistry 2012 and John F. Maher Award of ISPD 2006.
She currently serves on the editorial boards of JASN, KI, CJASN, NDT Theme Editor, Am J Nephrol, Nephron Clinical Practice (Associate Editor), J Renal Nutrition, J Diabetes, Kidney Medicine and Renal Replacement Therapy (Associate Editor), etc and is Editor-in-Chief of European Medical Journal-Nephrology. She was Associate Editor of AJKD and International Editor of CJASN previously. She chairs the Scientific Program Committee (SPC) of 40th congress of ISRNM 2022 and is the End-Stage Kidney Disease Theme Chair of WCN 2022 SPC.
She has published over 180 original articles, 13 book chapters and given over 120 invited lectures in international, regional and national meetings. Her main research interests are cardiovascular, metabolic and nutrition complications in CKD & dialysis & clinical trials.
Dr. Abduzhappar Gaipov is a board-certified nephrologist in Kazakhstan. He obtained his MD degree from Kh.A. Yassawi International Kazakh-Turkish University (Kazakhstan) and graduated his Doctorate program in Clinical Science (Internal Medicine) from National Scientific Medical Center (Kazakhstan).
Dr. Gaipov has completed 18 months ERA-EDTA research fellowship program in 2011-2012 years (Turkey). He has also completed his Postdoctoral Visiting Scholar supported by ISN Research Fellowship and spent 1.5 years between January 2017 to July 2018 at the University of Tennessee Health Science Center in Memphis, TN, USA.
Dr. Abduzhappar Gaipov is an active member of ISN, ERA-EDTA, TTS, Turkic World Transplantation Society and general secretary of Kazakhstan Society of Nephrologists, Dialysis, and Transplant Physicians. He also boards member of Young Nephrology Committee (YNC-ISN) and Deputy Chair of ISN NIS & Russia region. Currently, Dr. Gaipov started his academic career as an assistant professor at the Nazarbayev University School of Medicine.
Dr. Sunita Bavanandan graduated from the University of Queensland Australia in December, 1991. She obtained her qualifications as a Member of the Royal College of Physicians United Kingdom in 1997 and became a Fellow of the Royal College of Physicians Edinburgh in 2007. From 2003-2004 she obtained further training at the Leicester General Hospital, United Kingdom. Special interests are in Chronic Kidney Disease, Hypertension, Diabetic Kidney Disease and Peritoneal Dialysis.
She has been a member of several Malaysian Guidelines Development Committees including CPG on Management of Hypertension ( 3rd to 5th editions), CPG on Management of Chronic Kidney Disease in Adults ( 1st and 2nd editions) and CPG for the Management of Heart Failure 2019.
She contributes as an editor/author for chapters in the Malaysian Dialysis & Transplant Registry and the Malaysian Registry of Renal Biopsy. She is a Member of the Southeast Asia Glomerulonephritis Network and is involved in setting up the regional Southeast Asian PD registry (PROMISE) .
She is the Past-President of the Malaysian Society of Nephrology and is the Head of the Department of Nephrology, Hospital Kuala Lumpur, Malaysia.
Muh Geot Wong
Muh Geot Wong
Dr Wong obtained his MBBS in 2000 follows by MRCP (UK) and Nephrology training in Malaysia before migrating to Australia where he obtained his Fellowship in Nephrology and a PhD in Medicine from the University of Sydney in 2010.
He is currently a Renal Staff Specialist at the Royal North Shore Hospital (RNSH), and a Senior Clinical Lecturer of University of Sydney and University of NSW. He is a Clinician Researcher through his capacity as the Senior Research Fellow at the Kolling Institute and the George Institute for Global Health. He pursues a strong interest in research in understanding the pathomechanism of kidney fibrosis and has actively promoted the development of both clinical and pre-clinical research in delaying CKD progression in diabetic nephropathy, IgA nephropathy and management of cardiovascular complications associated with CKD.
He currently serves as the Head of the Renal Clinical trial unit at the RNSH and Co-Chair of the Research Group for the Chronic and Complex Medicine Network for Northern Sydney Lower Health District (NSLHD). He is the program Chair of the Nephrology and Transplantation Update Course for the Scientific Program and Education Committee (SPEC), ANZSN, and recently becomes a member of the Asia Pacific Society of Nephrology (ASPN) CME Committee and invited to be the Program Co-chair for the Nephrology Biennial Review Course, for the WCN in Melbourne, 2019.
He was elected as the Deputy Chair of the Oceania South East Asia Regional Board, International Society of Nephrology (ISN). He is a member of the KHA-CARI guideline writing group for “Infection control for haemodialysis unit” and the Working Group for Clinical Practice Guidelines for Diabetic Nephropathy for the APCN focusing on lower and middle income countries. He is the Subject Theme Editor for Journal Nephrology.
Professor Department of Nephrology Sanjay Gandhi Postgraduate Institute of Medical Sciences Raebareli Road, Lucknow-226014, INDIA
Hon. Secretary, Indian Society of Nephrology Member, South Asia Regional Board, Int Soc Nephrology Former Secretary, Indian Society of Organ Transplantation Former Secretary, Peritoneal Dialysis Society of India Former, Treasurer, Indian Society of Nephrology
Yusuke Suzuki is currently Professor of Department of Nephrology in Graduate School of Juntendo University and Professor of Department of Nephrology in Juntendo University Faculty of Medicine, Tokyo. His academic positions include Directors of Japanese Society of Nephrology (JSN), Councilor of Japanese Society of Internal Medicine, Japanese Society of Dialysis Therapy, Japanese Society of Hypertension, ISN council, Liaison officer in ISN sister renal center program for JSN/Vietnam, Chief Researcher of Special Research Group of IgA Nephropathy in Progressive Renal Diseases Research from Japanese Ministry of Health, Labor and Welfare, Chief Researcher of biomarker project on IgA nephropathy from Research on Intractable Disease from Japan Agency for Medical Research and Development. His research mainly focused on the pathogenesis of IgA nephropathy. His studies were supported more than 70 scientific research grants. He has more than 160 peer reviewed English publications.
Liz Lightstone is Professor of Renal Medicine at the Centre for Inflammatory Disease, Faculty of Medicine, Imperial College London, and Consultant Nephrologist at Imperial College Healthcare NHS Trust Renal and Transplant
After a PhD/postdoc in Immunology, and with a longstanding interest in health inequalities facing minority groups with CKD, her research now focuses on Lupus Nephritis (LN) and pregnancy in women with CKD. She pioneered steroid minimizing regimens for LN, influenced global LN trials design, developed novel approaches to assess adherence, identified biomarkers of pre-eclampsia in women with CKD and founded the UK CKD and Pregnancy
national registry. Committed to ensuring the patient voice is heard, she is global co-chair of the SONG-GD initiative which aims to define core outcomes critical to patients and healthcare professionals. She has published extensively, contributed to NICE guidance in LN and pregnancy and co-authored the Renal Association Guideline on Renal Disease and Pregnancy.
She jointly manages a renal/rheumatology lupus clinic following >400 LN patients and established and runs renal obstetric and pre-pregnancy counselling clinics; her clinical advice is sought worldwide. She has promoted academic training in nephrology through mentorship and supervision, and built capacity in EU and beyond by training visiting fellows who have gone on to establish LN and Obstetric Renal Clinics back home.
Other Contributions to National and International Kidney endeavours – Co-Chair UKKRC Glomerulonephritis Clinical Study Group; previously on Renal Association Executive & recently chaired RA group providing evidence-based advice on shielding from COVID-19 for patients with autoimmune CKD. CI/PI on LN/C3GN RCTs. Advocate for women in nephrology and now elected Council member of Women in Nephrology. Service to ISN: regular contributions to WCN; 2018 ISN WKD: as Renal Association lead organized national conference on Pregnancy & Kidney Disease; advocated for and arranged open access for key articles on women’s health & kidney disease.
Dibya Singh Shah
Dibya Singh Shah
Present Designation: Professor of Medicine
Present Affiliations: Head of Nephrology and Transplant Medicine, Institute of Medicine, Tribhuvan University Teaching Hospital
-She led the first successful renal transplantation program in Nepal 2008
-she has mentored many DM Nephrology trainees and residents she
-she led the committee for the revision and implementation of regulations of human organ transplant act and deceased organ donation act of Nepal.
– Chair of Human organ coordination committee of Nepal
-Co -chair south Asia committee and council member of International society of Nephrology
-Council member of Asian society of transplantation
-Vice President of nephrology urology and transplant society of SAARC
-Secretary General of Nepal society of Nephrology
-Secretary General of Nepal transplantation society
(Awards)- awarded by the President of Nepal- “Janashewashree first “
(Publications)-Around 100 publications in national and international journals and a book chapter.
Prof. Vladimir Tesar, MD, PhD, MBA, FASN, FERA, born May 5, 1957,
Graduated form Charles University in Prague, Professor of Medicine and Head of Department of Nephrology, General University Hospital, Charles University, Prague (since 2003), 1999 – 2005 vice-dean for research and science, 1st School of Medicine, Charles University, Prague.
Member of ISN (since 1993), since 2017 vice-chair of CEE Regional Board and the Council of ISN
Member of the Council of ERA/EDTA (2011 – 2014), chair of the board of the Immunonephrology Working Group of ERA-EDTA (since 2015)
President of the Czech Society of Nephrology (1999 – 2004, 2010 – 2012 and 2016-2020)
Member of the editorial board of CJASN, Nephrology,Dialysis, Transplantation and Journal of Nephrology
Longterm interest in glomerular disease, inherited diseases of the kidney and cardiovascular complications of kidney disease, more than 400 original publications according to Pubmed, H-index 34